Vantive Announces Agreement to Divest Majority of Hemodialysis Assets and Associated Operations to Rockwell Medical
PR Newswire•03/11/2026•06:01 ET
2
Key Highlights
- ➤Rockwell Medical to acquire Vantive’s majority hemodialysis assets and operations
- ➤Acquisition includes HD concentrates, monitors, water systems, consumables and technical services
- ➤Transaction expected to close mid-2027, pending regulatory approvals and customary conditions
- ➤Vantive’s Medolla, Italy manufacturing facility will transfer to Rockwell Medical
- ➤Vantive’s dialyzer portfolio, including Theranova, is excluded from the transaction
Expert Statements
Chris Toth, CEO of Vantive
“We see a significant opportunity to close the gap between the care we know is possible and the care patients and providers experience today”
Chris Toth, CEO of Vantive
“This announcement brings Vantive's ambition into sharper focus. We are applying our expertise and scale to make care easier to access, simpler to deliver and more effective for the people who rely on our therapies. Whether that care happens at home over many years or in the ICU during a critical moment, our goal is to help ensure the right therapy can be delivered at the right time, with greater confidence for care teams.”
Chris Toth, CEO of Vantive
“We are confident Rockwell Medical is well positioned to support the continued growth and development of this important therapy. With a singular focus on hemodialysis, Rockwell Medical is deeply committed to accelerating the progress that our team has made. As a result, we believe the combined business will benefit from increased investment, creating new opportunities for innovation and growth. We are committed to working together through the transition to help ensure continuity of care and reliable access to the products, services and support that patients and care providers depend on.”
Mark Strobeck, Ph.D., President and CEO of Rockwell Medical
“This transaction represents an exciting opportunity to build on the strong foundation established by the Vantive team over many decades”
Mark Strobeck, Ph.D., President and CEO of Rockwell Medical
“As a company singularly focused on hemodialysis, we are committed to advancing the quality, reliability and customer support that providers and patients depend on every day. We believe this portfolio has significant opportunities for continued growth, and we look forward to bringing together complementary capabilities to better serve dialysis providers worldwide and further strengthen our position in the global hemodialysis market.”
Vantive Announces Agreement to Divest Majority of Hemodialysis Assets and Associated Operations to Rockwell Medical PR Newswire
Sharpens Vantive's Focus on Home Dialysis and Critical Care
Get started
Create a free account to read the full story.